Diamyd Medical
is a diabetes company that engages in the pharmaceutical development and investments in medical and stem cell technology... Read moreDiamyd Medical
is a diabetes company that engages in the pharmaceutical development and investments in medical and stem cell technology... Read more
News
Feb 09, 2026
FinanzNachrichten
Diamyd Medical: Diamyd Medical AB: Diamyd Medical receives Notice of Allowance for key retogatein US patent
Jan 28, 2026
Cision
Press Release: Diamyd Medical : Quarterly Report 1 25/26
Jan 13, 2026
Marketscreener
Diamyd Medical: Diamyd Medical: a Swedish example of Nobel Prize science in action
Jan 09, 2026
Cision
Press Release: Diamyd Medical : Diamyd Medical's lead immunotherapy for type 1 diabetes receives global non-proprietary name retogatein
Dec 30, 2025
Pharmabiz
Diamyd Medical: Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes phase 3 trial following US FDA alignment and guidance
Dec 02, 2025
Cision
Press Release: Diamyd Medical : Annual Report 2024/2025
Nov 14, 2025
Seeking Alpha
Diamyd Medical: Diamyd Medical AB (publ) (DYMDF) Panel Discussion on Advances and Challenges in Type 1 Diabetes for World Diabetes Day Transcript
Nov 14, 2025
FinanzNachrichten
Diamyd Medical: Diamyd Medical AB: Diamyd Medical's pivotal Phase 3 Type 1 Diabetes trial clears last safety review ahead of early readout in March 2026
Nov 13, 2025
Diamyd Medical Youtube Channel
Diamyd Medical posted a video "There's no insulin like your own" on YOUTUBE
Oct 08, 2025
Marketscreener
Diamyd Medical: Diamyd Medical AB Reports Earnings Results for the Full Year Ended August 31, 2025